[1] Finn RS, Crown JP, Lang I, et al. Thecyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozoleversus letrozole alone as first-line treatment of oestrogen receptor-positive,HER2-negative, advanced breast cancer (...
题图来源:站酷海洛PLUS Cristofanilli M, Rugo HS, Im SA, et al. Overall Survival With Palbociclib And Fulvestrant in Women With HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-Blind, Phase 3 Randomized Study. Clin Cancer Res. 2022 May 12;clincanres.0305.2022. doi: 10.11...
Thecyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozoleversus letrozole alone as first-line treatment of oestrogen receptor-positive,HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2study. Lancet Oncol. 2015. 16(1): 25-35. [2] /record/...
[1] Finn RS, Crown JP, Lang I, et al. Thecyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozoleversus letrozole alone as first-line treatment of oestrogen receptor-positive,HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2study. Lancet Onc...
The double-blind PALOMA-3 study randomized 521 patients with advanced breast cancer whose disease progressed on or following endocrine treatment in a 2:1 ratio to standard 500 mg of fulvestrant plus either 125 mg of daily oral palbociclib (n = 347) every 3 weeks or placebo (n = 174). ...
In the PALOMA-3 study, the combination of the CDK4 and CDK6 inhibitor palbociclib and fulvestrant was associated with significant improvements in progression-free survival compared with fulvestrant plus placebo in patients with metastatic breast cancer. Identification of patients most suitable for the ad...
The aim of this qualitative descriptive exploratory study was to investigate the perception of nursing undergraduate students on the forms of expression of violence in the college environment. Data were collected using semi-structured in... ZA Pires Scherer,EA Scherer,P Tamaris Rossi,... - 《Revis...
Cristofanilli M, Rugo HS, Im SA, et al. Overall Survival With Palbociclib And Fulvestrant in Women With HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-Blind, Phase 3 Randomized Study. Clin C...
1 文献来源Magee LA,von Dadelszen P,Singer J,et al. The CHIPS randomized controlled trial (control of hypertension in pregnancy study) :Is severe hypertension just an elevated blood pressure?[J]. Hypertension,2016,68(5):1153-1159. 关键词:妊娠期高血压抗高血压治疗 ...
[1] Finn RS, Crown JP, Lang I, et al. Thecyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozoleversus letrozole alone as first-line treatment of oestrogen receptor-positive,HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2study. Lancet Onc...